{"id":"https://openalex.org/W107883169","doi":"https://doi.org/10.33588/rn.3903.2004110","title":"Evoluci\u00f3n temporal de TNF-a, VCAM-1, IL-4, IL-10, neopterina y CD-30 en pacientes tratados con interfer\u00f3n","display_name":"Evoluci\u00f3n temporal de TNF-a, VCAM-1, IL-4, IL-10, neopterina y CD-30 en pacientes tratados con interfer\u00f3n","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W107883169","doi":"https://doi.org/10.33588/rn.3903.2004110","mag":"107883169","pmid":"https://pubmed.ncbi.nlm.nih.gov/15284959"},"language":"es","primary_location":{"id":"doi:10.33588/rn.3903.2004110","doi":"https://doi.org/10.33588/rn.3903.2004110","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.3903.2004110","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077878703","display_name":"Ernesto Manuel Cebri\u00e1n P\u00e9rez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158603","display_name":"Complejo Hospitalario de Pontevedra","ror":"https://ror.org/016cxc226","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158603"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ernesto M. Cebri\u00e1n P\u00e9rez","raw_affiliation_strings":["Servicio de Neurolog\u00eda, Complejo Hospitalario de Pontevedra, Pontevedra, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Neurolog\u00eda, Complejo Hospitalario de Pontevedra, Pontevedra, Spain","institution_ids":["https://openalex.org/I4210158603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111060223","display_name":"Jos\u00e9 Mar\u00eda Prieto Gonz\u00e1lez","orcid":"https://orcid.org/0009-0007-3055-349X","observed_orcids":["https://orcid.org/0009-0007-3055-349X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Mar\u00eda Prieto Gonz\u00e1lez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111393019","display_name":"Manuela Lema Bouzas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuela Lema Bouzas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037928401","display_name":"Mar\u00eda del Campo-Amigo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M\u00aa del Campo Amigo Jorr\u00edn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085714472","display_name":"Susana Iglesias G\u00f3mez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susana Iglesias G\u00f3mez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100970784","display_name":"Manuel Noya Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158603","display_name":"Complejo Hospitalario de Pontevedra","ror":"https://ror.org/016cxc226","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158603"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Noya Garc\u00eda","raw_affiliation_strings":["Servicio de Neurolog\u00eda, Complejo Hospitalario de Pontevedra"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Neurolog\u00eda, Complejo Hospitalario de Pontevedra","institution_ids":["https://openalex.org/I4210158603"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0129698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"39","issue":"03","first_page":"213","last_page":"213"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/interferon-therapy","display_name":"interferon therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9440000057220459},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":0.9279999732971191},{"id":"https://openalex.org/keywords/il-4","display_name":"IL-4","score":0.906000018119812},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":1.0},{"id":"https://openalex.org/keywords/neopterin","display_name":"neopterin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cd30","display_name":"CD30","score":0.9679999947547913},{"id":"https://openalex.org/keywords/serum-cytokines","display_name":"serum cytokines","score":0.8529999852180481},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/treatment-monitoring","display_name":"treatment monitoring","score":0.6190000176429749},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2776603314","wikidata":"https://www.wikidata.org/wiki/Q908292","display_name":"Neopterin","level":2,"score":0.9464666843414307},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7481049299240112},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6052733063697815},{"id":"https://openalex.org/C2910198813","wikidata":"https://www.wikidata.org/wiki/Q1851162","display_name":"Interferon beta-1b","level":4,"score":0.6011868119239807},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5200093388557434},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49559295177459717},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.43491360545158386},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36061590909957886},{"id":"https://openalex.org/C2994247566","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta","level":3,"score":0.23216405510902405}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D015847","descriptor_name":"Interleukin-4","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D017730","descriptor_name":"Ki-1 Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019010","descriptor_name":"Vascular Cell Adhesion Molecule-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019798","descriptor_name":"Neopterin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.33588/rn.3903.2004110","doi":"https://doi.org/10.33588/rn.3903.2004110","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.3903.2004110","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},{"id":"pmid:15284959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15284959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de neurologia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087939913","https://openalex.org/W2023389632","https://openalex.org/W2049419771","https://openalex.org/W1978724534","https://openalex.org/W7004828450","https://openalex.org/W2059058851","https://openalex.org/W1503190668","https://openalex.org/W2152770320","https://openalex.org/W2071828324","https://openalex.org/W2081814246"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Interferon":[1],"(IFN)":[2],"diminishes":[3],"the":[4,43,48,76,117,143,147,211],"outbreaks":[5],"of":[6,16,45,51,79,130,142,146,167,179,210,214],"multiple":[7],"sclerosis":[8],"(MS)":[9],"and":[10,22,26,57,97,112,133,149,151,171,176],"slows":[11],"down":[12],"its":[13,37,80,185],"progression.":[14],"Follow-up":[15],"patients":[17,60,90,222],"is":[18,216],"performed":[19],"using":[20],"clinical":[21,77,144,197],"resonance":[23],"imaging":[24],"parameters,":[25],"no":[27],"biological":[28],"markers":[29],"are":[30],"available":[31],"that":[32,182],"allow":[33],"us":[34],"to":[35,124],"determine":[36,65,125],"efficiency.":[38],"AIMS:":[39],"1.":[40],"To":[41,64,73],"discover":[42],"effects":[44],"IFN":[46,99,183],"on":[47],"serum":[49,156,212],"levels":[50,129,139,213],"TNF-alpha,":[52],"IL-4,":[53],"IL-10,":[54],"VCAM-1,":[55],"neopterin":[56],"CD-30":[58,132],"in":[59,82,219],"with":[61,91,224],"MS;":[62],"2.":[63],"how":[66],"these":[67],"modifications":[68],"evolve":[69],"over":[70,107],"time;":[71],"3.":[72],"find":[74],"out":[75],"value":[78],"determination":[81,209],"isolation.":[83],"PATIENTS":[84],"AND":[85],"METHODS:":[86],"We":[87],"studied":[88],"19":[89],"MS":[92],"who":[93],"were":[94,102,135],"clinically":[95],"stable":[96],"undergoing":[98],"therapy.":[100],"Samples":[101],"obtained":[103],"every":[104],"3":[105],"months":[106,160,178,191],"a":[108,154,168,194,202],"2.5":[109],"year":[110],"period":[111],"always":[113],"immediately":[114],"before":[115],"injecting":[116],"drug.":[118],"The":[119,165,207],"ELISA":[120],"method":[121],"was":[122],"used":[123],"interleukins.":[126],"RESULTS:":[127],"Serum":[128],"neopterin,":[131],"VCAM-1":[134],"not":[136,200,217],"modified,":[137],"TNF-alpha":[138],"oscillated":[140],"regardless":[141],"status":[145],"patient":[148],"IL-4":[150,170],"IL-10":[152,172],"had":[153],"significant":[155,169],"peak":[157,173],"at":[158],"9-12":[159],"after":[161,189],"beginning":[162],"treatment.":[163],"CONCLUSIONS:":[164],"existence":[166],"between":[174],"6":[175],"12":[177],"therapy":[180],"indicates":[181],"reaches":[184],"possible":[186],"immunomodulatory":[187],"effect":[188],"several":[190],"and,":[192],"therefore,":[193],"poor":[195],"initial":[196],"response":[198],"must":[199],"be":[201],"reason":[203],"for":[204],"discontinuing":[205],"medication.":[206],"specific":[208],"IL":[215],"useful":[218],"following":[220],"up":[221],"treated":[223],"IFN.":[225]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}